RK Pharma

RK Pharma is a private, US-based generic drug company established in 2018, headquartered in San Diego with a corporate office in New Jersey and a key manufacturing facility in Pearl River, NY. The company's strategy centers on developing complex generics, particularly injectables, sterile ophthalmic, and dermal products, aiming to provide affordable alternatives in the healthcare market. With a focus on first generic opportunities and formulation-challenged products, RK Pharma leverages its internal development and manufacturing expertise while partnering for solid oral dosage forms. It is currently in the commercial stage, generating revenue from its developed products.

Integrated development, regulatory, and manufacturing platform for complex generic pharmaceuticals, specializing in sterile injectables, ophthalmic, and dermal products.

RK Pharma competes in the generic pharmaceuticals sector against large, diversified players like Teva, Viatris, and Sun Pharma, as well as specialized generic companies focused on complex products (e.g., Hikma, Pfizer's Hospira). Its differentiation lies in its integrated sterile manufacturing and focused development on formulation-challenged products, aiming for niches with higher barriers to entry.